657 related articles for article (PubMed ID: 24100264)
41. MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway.
Wu Z; Wang J; Feng J; Ying L
Hum Exp Toxicol; 2022; 41():9603271221084672. PubMed ID: 35303413
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
[TBL] [Abstract][Full Text] [Related]
46. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
47. Activation of hepatic stellate cells is suppressed by microRNA-150.
Zheng J; Lin Z; Dong P; Lu Z; Gao S; Chen X; Wu C; Yu F
Int J Mol Med; 2013 Jul; 32(1):17-24. PubMed ID: 23604143
[TBL] [Abstract][Full Text] [Related]
48. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
Pan W; Wang Y; Zhao C
Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
[TBL] [Abstract][Full Text] [Related]
49. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
50. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
[TBL] [Abstract][Full Text] [Related]
51. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
52. Substance P promotes hepatic stellate cell proliferation and activation via the TGF-β1/Smad-3 signaling pathway.
Peng L; Jia X; Zhao J; Cui R; Yan M
Toxicol Appl Pharmacol; 2017 Aug; 329():293-300. PubMed ID: 28647476
[TBL] [Abstract][Full Text] [Related]
53. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
55. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling.
Yuan BY; Chen YH; Wu ZF; Zhuang Y; Chen GW; Zhang L; Zhang HG; Cheng JC; Lin Q; Zeng ZC
Radiat Res; 2019 Dec; 192(6):621-629. PubMed ID: 31560641
[TBL] [Abstract][Full Text] [Related]
57. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line.
Meurer SK; Alsamman M; Sahin H; Wasmuth HE; Kisseleva T; Brenner DA; Trautwein C; Weiskirchen R; Scholten D
PLoS One; 2013; 8(2):e56116. PubMed ID: 23437087
[TBL] [Abstract][Full Text] [Related]
59. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
60. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.
Carson JP; Robinson MW; Ramm GA; Gobert GN
Mol Biol Rep; 2021 Dec; 48(12):7677-7688. PubMed ID: 34648138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
